Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | LY3435151 |
Trade Name | |
Synonyms | LY 3435151|LY-3435151 |
Drug Descriptions |
LY3435151 is an antibody that targets and binds to CD226, a cell surface glycoprotein, potentially leading to the activation of the antitumor immune response (NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C180889 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
LY3435151 | LY3435151 | 0 | 1 |
LY3435151 + Pembrolizumab | LY3435151 Pembrolizumab | 0 | 1 |